161 related articles for article (PubMed ID: 21573767)
1. Heterogeneous distribution of K-ras mutations in primary colon carcinomas: implications for EGFR-directed therapy.
Oltedal S; Aasprong OG; Møller JH; Kørner H; Gilje B; Tjensvoll K; Birkemeyer EM; Heikkilä R; Smaaland R; Nordgård O
Int J Colorectal Dis; 2011 Oct; 26(10):1271-7. PubMed ID: 21573767
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology.
Perez K; Walsh R; Brilliant K; Noble L; Yakirevich E; Breese V; Jackson C; Chatterjee D; Pricolo V; Roth L; Shah N; Cataldo T; Safran H; Hixson D; Quesenberry P
Exp Mol Pathol; 2013 Aug; 95(1):74-82. PubMed ID: 23528430
[TBL] [Abstract][Full Text] [Related]
3. Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue.
Miyamae Y; Shimizu K; Mitani Y; Araki T; Kawai Y; Baba M; Kakegawa S; Sugano M; Kaira K; Lezhava A; Hayashizaki Y; Yamamoto K; Takeyoshi I
J Mol Diagn; 2010 Mar; 12(2):257-64. PubMed ID: 20093389
[TBL] [Abstract][Full Text] [Related]
4. Detection of occult metastases in sentinel lymph nodes from colon cancer patients by K-ras mutation peptide nucleic acid clamp PCR.
Oltedal S; Gilje B; Kørner H; Aasprong OG; Tjensvoll K; Heikkilä R; Smaaland R; Nordgård O
Ann Surg; 2010 Jun; 251(6):1087-91. PubMed ID: 20485143
[TBL] [Abstract][Full Text] [Related]
5. High sensitivity of reverse-hybridization methodology in the detection of KRAS mutations from formalin-fixed paraffin-embedded colorectal cancer samples.
De Miglio MR; Mura A; Uras MG; Manca A; Contini M; Murgia L; Zinellu A; Sotgia S; Carru C; Massarelli G; Cossu-Rocca P
Diagn Mol Pathol; 2010 Dec; 19(4):201-8. PubMed ID: 21052001
[TBL] [Abstract][Full Text] [Related]
6. KRAS detection in colonic tumors by DNA extraction from FTA paper: the molecular touch-prep.
Petras ML; Lefferts JA; Ward BP; Suriawinata AA; Tsongalis GJ
Diagn Mol Pathol; 2011 Dec; 20(4):189-93. PubMed ID: 22089345
[TBL] [Abstract][Full Text] [Related]
7. [K-ras mutational status and tumour-infiltrating lymphocytes in human colon cancer: state of the art and future perspectives].
Kocián P; Sedivcová M; Drgáč J; Cerná K; Hoch J; Kodet R; Bartůňková J; Spíšek R; Fialová A
Rozhl Chir; 2012 Aug; 91(8):427-32. PubMed ID: 23153426
[TBL] [Abstract][Full Text] [Related]
8. Oncosuppressor methylation: a possible key role in colon metastatic progression.
Tommasi S; Pinto R; Petriella D; Pilato B; Lacalamita R; Santini D; Zito F; Colucci G; Paradiso A; Silvestris N
J Cell Physiol; 2011 Jul; 226(7):1934-9. PubMed ID: 21506124
[TBL] [Abstract][Full Text] [Related]
9. Comparison of COBAS 4800 KRAS, TaqMan PCR and high resolution melting PCR assays for the detection of KRAS somatic mutations in formalin-fixed paraffin embedded colorectal carcinomas.
Harlé A; Busser B; Rouyer M; Harter V; Genin P; Leroux A; Merlin JL
Virchows Arch; 2013 Mar; 462(3):329-35. PubMed ID: 23400679
[TBL] [Abstract][Full Text] [Related]
10. Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.
Tuononen K; Mäki-Nevala S; Sarhadi VK; Wirtanen A; Rönty M; Salmenkivi K; Andrews JM; Telaranta-Keerie AI; Hannula S; Lagström S; Ellonen P; Knuuttila A; Knuutila S
Genes Chromosomes Cancer; 2013 May; 52(5):503-11. PubMed ID: 23362162
[TBL] [Abstract][Full Text] [Related]
11. Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice.
Sun L; Zhang Q; Luan H; Zhan Z; Wang C; Sun B
J Exp Clin Cancer Res; 2011 Mar; 30(1):30. PubMed ID: 21414214
[TBL] [Abstract][Full Text] [Related]
12. Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.
Van Damme N; Deron P; Van Roy N; Demetter P; Bols A; Van Dorpe J; Baert F; Van Laethem JL; Speleman F; Pauwels P; Peeters M
BMC Cancer; 2010 May; 10():189. PubMed ID: 20459770
[TBL] [Abstract][Full Text] [Related]
13. EGFR and K-ras mutation analysis in non-small cell lung cancer: comparison of paraffin embedded versus frozen specimens.
Gallegos Ruiz MI; Floor K; Rijmen F; Grünberg K; Rodriguez JA; Giaccone G
Cell Oncol; 2007; 29(3):257-64. PubMed ID: 17452778
[TBL] [Abstract][Full Text] [Related]
14. [Correlation between the presence of Kras mutation and the presence of the proteins epiregulin and amphiregulin in colon cancer tissue].
Levi Y; Barshack I; Avivi K; Bar-ILan D; Gutman M; Aderka D; Berger R; Yacobi R
Harefuah; 2013 Jun; 152(6):326-9, 369. PubMed ID: 23885463
[TBL] [Abstract][Full Text] [Related]
15. Inter- and intra-tumor profiling of multi-regional colon cancer and metastasis.
Kogita A; Yoshioka Y; Sakai K; Togashi Y; Sogabe S; Nakai T; Okuno K; Nishio K
Biochem Biophys Res Commun; 2015 Feb; 458(1):52-6. PubMed ID: 25623536
[TBL] [Abstract][Full Text] [Related]
16. Prognostic relevance of occult metastases detected by cytokeratin 20 and mucin 2 mRNA levels in sentinel lymph nodes from colon cancer patients.
Nordgård O; Oltedal S; Aasprong OG; Søreide JA; Søreide K; Tjensvoll K; Gilje B; Heikkilä R; Guriby M; Lothe RA; Smaaland R; Kørner H
Ann Surg Oncol; 2012 Nov; 19(12):3719-26. PubMed ID: 22752373
[TBL] [Abstract][Full Text] [Related]
17. Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.
Kalikaki A; Koutsopoulos A; Trypaki M; Souglakos J; Stathopoulos E; Georgoulias V; Mavroudis D; Voutsina A
Br J Cancer; 2008 Sep; 99(6):923-9. PubMed ID: 19238633
[TBL] [Abstract][Full Text] [Related]
18. Targeted data-independent acquisition for mass spectrometric detection of RAS mutations in formalin-fixed, paraffin-embedded tumor biopsies.
Kim YJ; Chambers AG; Cecchi F; Hembrough T
J Proteomics; 2018 Oct; 189():91-96. PubMed ID: 29684684
[TBL] [Abstract][Full Text] [Related]
19. KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies.
Maus MK; Grimminger PP; Mack PC; Astrow SH; Stephens C; Zeger G; Hsiang J; Brabender J; Friedrich M; Alakus H; Hölscher AH; Lara P; Danenberg KD; Lenz HJ; Gandara DR
Lung Cancer; 2014 Feb; 83(2):163-7. PubMed ID: 24331409
[TBL] [Abstract][Full Text] [Related]
20. Detection of KRAS codon 12 and 13 mutations by mutant-enriched PCR assay.
Chang YS; Er TK; Lu HC; Yeh KT; Chang JG
Clin Chim Acta; 2014 Sep; 436():169-75. PubMed ID: 24863805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
